Drugs / GW468816
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00218465 | Aug 2006 → Jun 2009 | nicotine dependence | Massachusetts General Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW468816 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00218465 ↗ |
| Action | Inhibit | “The purpose of this study is to evaluate the efficacy of the glycine antagonist, GW468816, compared with placebo on duration of abstinence and rates of relapse in recently quit...” NCT00218465 ↗ |
| Modality | Small molecule | — CHEMBL1207366 ↗ |